AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, ...

Biotechnology organizations are turning in growing numbers to alternative strategies centered on strengthening the performance of already-approved drugs. Oncotelic Therapeutics is developing ...

Artificial intelligence played a prominent role at this week’s Bio International Convention in San Diego, the largest biotech ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, ...

After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #5 is about a biotech by the name of Cytokinetics (CYTK). The reason why I believe that it is important ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #17 is a biotech by the name of Tempest Therapeutics (TPST). I want to state that I have chosen to ...